Team Kapital sources new equity funding for technology companies - in biotech, cleantech and IT. We typically source funds from North American investors, financial investors or corporate venture teams – a market with huge enthusiasm for the innovation sector – but also have access to the usual VC suspects across Europe. We focus primarily on growth capital but are well known for our contentious work with startups too: “Better Startups: bring back Grand Tours"

Latest Articles

Chasing the dragon? Setting up in China #1

Chasing the dragon? Setting up in China #1

So, as the 'white wine'-induced hangover wears off, I realise that I have a new addiction: China. China is a heady drug for anyone invo...

Read More

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

So the global pharma and biotech industry still has a pipeline problem: cost per new drug is sky rocketing, volume of new approvals continue...

Read More

Live with passion

Live with passion

So I managed to fit in a single day's skiing last Sunday. Nothing very remarkable about that, you might think, until you learn that I haven...

Read More

Seed investors leave whilst party in full swing?

Seed investors leave whilst party in full swing?

With the festive season upon us we should remember that sometimes it is best to encourage bleary-eyed, slightly worse-for-wear friends to le...

Read More


“Success means getting up just one more time than you fall down”–FortunePick Europe  #LessonLearned

“There is no idea that can't be improved upon: never settle, always evolve”–Michael Parks, Pick360  #LessonLearned

“Don't be afraid of failure but celebrate it and know what not to do next time”–Jeremy Rudolph, Palo Alto   #LessonLearned